Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California.
| Revenue (Most Recent Fiscal Year) | $312.97M |
| Net Income (Most Recent Fiscal Year) | $-208.73M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 4.98 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.92 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -54.87% |
| Net Margin (Trailing 12 Months) | -54.98% |
| Return on Equity (Trailing 12 Months) | -33.48% |
| Return on Assets (Trailing 12 Months) | -25.34% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.51 |
| Quick Ratio (Most Recent Fiscal Quarter) | 4.24 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.03 |
| Inventory Turnover (Trailing 12 Months) | 7.65 |
| Book Value per Share (Most Recent Fiscal Quarter) | $7.35 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.66 |
| Earnings per Share (Most Recent Fiscal Year) | $-2.99 |
| Diluted Earnings per Share (Trailing 12 Months) | $-3.25 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 59.92M |
| Free Float | 58.11M |
| Market Capitalization | $1.73B |
| Average Volume (Last 20 Days) | 1.21M |
| Beta (Past 60 Months) | 2.54 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.01% |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |